| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
Department of Radiology and Clinical Research Institute, Seoul National
University Hospital and the Institute of Radiation Medicine, SNUMRC 28
Yongon-dong, Chongno-gu, Seoul 110-744, Korea.
2
Contrast Media Research, Schering, Mullerstra. 178, 13353 Berlin,
Germany.
OBJECTIVE. The objective of this study was to compare enhancement patterns of a blood-pool contrast agent, Gadomer-17, with those of gadopentetate dimeglumine in bacterial abscesses and VX2 carcinoma in rabbits.
MATERIALS AND METHODS. Fourteen rabbits with experimentally induced bacterial abscesses and VX2 carcinoma in both thighs underwent dynamic contrast-enhanced MR imaging with Gadomer-17 and gadopentetate dimeglumine at a 24-hr interval. The enhancement ratios (postcontrast to precontrast signal intensities) of lesions in the same animal were assessed and correlated with microvessel density.
RESULTS. For Gadomer-17, the enhancement ratio of the abscesses (1.66 ± 0.39) peaked 15 min after the injection, while that of the carcinoma (2.05 ± 0.16) peaked at 10 min. The enhancement ratios of the carcinoma were consistently higher than those of the abscesses up to 30 min. For gadopentetate dimeglumine, peak enhancement ratio of the abscesses (2.30 ± 0.75) was seen 5 min after the injection, while that of the carcinoma (2.32 ± 0.51) was seen at 3 min. The enhancement ratios of the carcinomas were significantly higher at 1 min, but singificantly lower at 20-30 min, compared with those of the abscesses, as a result of rapid decrease of enhancement ratios in the carcinomas. The microvessel density was 9.8 ± 5.2 vessels per field of view for the abscesses and 36.3 ± 9.5 vessels per field of view for the carcinoma (p <0.001).
CONCLUSION. Delayed peak enhancement and slow decay were found in both bacterial abscess and VX2 carcinoma with Gadomer-17, whereas early peak enhancement and rapid decay were found especially in VX2 carcinoma with gadopentetate dimeglumine. Enhancement ratios on MR imaging with a blood-pool contrast agent correlated well with the microvessel density in bacterial abscess and VX2 carcinoma.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Ni, F. Chen, G. Marchal, T. J. Kim, W. K. Moon, and S. N. Goldberg Differentiation of Residual Tumor from Benign Periablational Tissues after Radiofrequency Ablation: The Role of MR Imaging Contrast Agents * Drs Kim and Moon respond: * Dr Goldberg responds: Radiology, November 1, 2005; 237(2): 745 - 749. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor Radiology, February 1, 2005; 234(2): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Lee, W. K. Moon, H.-J. Weinmann, S. J. Kim, J. H. Kim, S. H. Park, T. J. Kim, C. J. Yoon, Y. H. Kim, E. Y. Cho, et al. Contrast-enhanced MR Imaging of Postoperative Scars and VX2 Carcinoma in Rabbits: Comparison of Macromolecular Contrast Agent and Gadopentetate Dimeglumine Radiology, October 1, 2003; 229(1): 132 - 139. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
